Elsevier

Virology

Volume 185, Issue 1, November 1991, Pages 460-463
Virology

Short communication
Association of hepatitis B viral precore mutations with fulminant hepatitis B in Japan

https://doi.org/10.1016/0042-6822(91)90799-HGet rights and content

Abstract

We studied the precore DNA sequences of hepatitis B viral genomes in five patients with fulminant hepatitis B and in five with acute self-limited hepatitis B from Japan. Using the polymerase chain reaction, three to four independent HBV DNA clones from each patient were obtained and analyzed. We demonstrated that patients with fulminant hepatitis B carried HBV genomes with a G to A mutation at nucleotide positions 1898 (five of five patients; 18 of 18 clones, 100%) and 1901 (five of five patients; 12 of 18 clones, 66%) in the precore region. The first mutation results in an in-phase stop codon (TAG) in the precore open reading frame and the absence of HBeAg production. In contrast, a G to A mutation was found in 6 of 16 clones (37%) in position 1898 and in 0 of 16 clones (0%) in position 1901 from patients with acute self-limited hepatitis. We concluded that both of the precore mutations are commonly associated with fulminant hepatitis B and may contribute to the pathogenesis of fulminant hepatitis. A hypothetical model for the biological significance of these two mutations is proposed.

References (26)

  • K. Kanai et al.

    Lancet

    (1990)
  • A. Weiner et al.

    Lancet

    (1990)
  • J.A. Garson et al.

    Lancet

    (1990)
  • M.R. Brunetto et al.

    J. Hepatol.

    (1990)
  • Y. Kosaka et al.

    Gastroenterology

    (1991)
  • J. Bernuau et al.

    Semin. Liver Dis.

    (1986)
  • Fulminant hepatitis

    MMWR.

    (1984)
  • A.E. Read et al.

    Ann. Intern. Med.

    (1991)
  • T.I. Liang et al.

    J. Clin. Invest.

    (1989)
  • S. Kwok et al.

    Nature

    (1989)
  • Q-L. Choo et al.

    Science

    (1989)
  • G. Kuo et al.

    Science

    (1989)
  • H. Alter et al.

    N. Engl. J. Med.

    (1989)
  • Cited by (69)

    • Fatal fulminant primary hepatitis B virus infections with G1896A precore viral mutants in southeastern France

      2012, Clinics and Research in Hepatology and Gastroenterology
      Citation Excerpt :

      In the four fulminant and non-fulminant AHB reported here, it can be outlined that HBV genotype was D or E in AHB. The question of whether or not fulminant outcome after HBV infection is linked to precore G1896A HBV mutants has been raised in several studies, starting from initial descriptions of these viral strains in FHB [31,35,38,45,46]. Four studies conducted in Japan, where patients are mostly infected by HBV genotypes B or C, reported statistically significantly higher frequencies of G1896A mutants in FHB than in ASLHB.

    • Advances in hepatitis B virus infection

      2003, Transplantation Proceedings
    • High hepatitis B virus (HBV) DNA viral load as the most important risk factor for HBV reactivation in patients positive for HBV surface antigen undergoing autologous hematopoietic cell transplantation

      2002, Blood
      Citation Excerpt :

      Other HBV viral factors that might be involved in HBV reactivation are the presence of variants, notably, the G→A mutation at nucleotide 1896 in the precore region (A1896), which converts codon 28 for tryptophan to a stop codon23; and the double mutation in the basic core promoter (BCP) that consists of the A→T mutation at nucleotide 1762 and the G→A mutation at nucleotide 1764 (T1762/A1764).24 The precore A1896 stop mutation was reported to be an Andromeda strain that markedly increased HBV virulence and contributed to the development of fulminant hepatitis.25, 26 On the other hand, the BCP regulates transcription of pregenomic RNA, encodes core protein and HBV polymerase, and serves as a replicative intermediate for the synthesis of viral DNA.27

    • Viral genotype and hepatitis B virus DNA levels are correlated with histological liver damage in HBeAg-negative chronic hepatitis B virus infection

      2002, American Journal of Gastroenterology
      Citation Excerpt :

      In vitro studies (1–3) suggest that precore stop codon mutation (G to A mutation at nucleotide 1896—i.e., G1896 to A1896) and a dual-nucleotide mutation at the core promoter region (A to T and G to A at nucleotides 1762 and 1764, respectively—i.e., A1762/G1764 to T1762/A1764) abolish and reduce the production of HBeAg, respectively, but at the same time they facilitate more efficient viral replication. These HBV mutants have been reported to be associated with fulminant hepatitis (4–7), chronic active hepatitis (8, 9), and hepatocellular carcinoma (10–12) among HBeAg-negative patients. However, others, including our group, have found these HBV mutants in a large number of HBeAg-negative patients who had inactive liver disease (13–17).

    View all citing articles on Scopus
    View full text